12
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Disturbing effect of lockdown for COVID-19 on the incidence of infective endocarditis: a word of caution

      letter

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Sirs: At the end of December 2019, Chinese authorities reported several cases of acute respiratory syndrome in Wuhan City [1–3]. Also possible impact of underlying cardiovascular diseases on the prognosis of the respiratory syndrome were published [4, 5]. Since then, the COVID-19 virus spread all over the world and the Belgian government decided, as in other countries, to install a lockdown making only essential displacements possible and limiting consultations and interventions to only urgent and necessary indications, thereby limiting considerably the access to usual non-COVID 19 medical care. In summary, authorities gave one major advice: stay at home! At the same time, the major flu-like symptoms of COVID-19 pulmonary infections were widely communicated: fever, dyspnea and cough. Infective endocarditis (IE) is a serious disease with a high mortality and morbidity and its incidence and severity remain unchanged despite diagnostic and therapeutic improvements [6]. Early diagnosis and treatment is key to avoid major complications as embolic events and local extension of the infection with destruction of the valvular and peri-valvular tissue. Being alert to symptoms and signs of patients susceptible for IE is a prerequisite for this early strategy. However, the main symptoms of fever, dyspnea and cough in a critical patient can be easily mistaken for COVID-19 symptoms although they are also eye-openers in the diagnosis of IE. Since the initial publications on COVID-19 and the actual worldwide spread of the disease, more than 3.3 million coronavirus cases and 237,000 deaths are reported. These numbers create inherent fear in the population and together with the terrible images on television of overcrowded hospitals and governments advising staying home, it leads to aversion for hospitalization. This has been reflected in the number of patients presenting with acute myocardial infarction. Several countries have reported a reduction in approximately 40% in the number of myocardial infarction cases during the COVID-19 lockdown [7, 8]. Taking into consideration these aspects of COVID-19 and IE, and being afraid of a collateral damage of lockdown isolation on the detection of IE, we evaluated in our hospital the incidence of IE during the lockdown period and compared this with the period before, using our in hospital registry of IE. Patient population: Single center prospective registry of IE. The registry on IE started in 2015. From that moment the care for our endocarditis patients remained uniform including the liberal use of multimodality imaging when necessary [transthoracic (TTE), transoesophageal echocardiography (TOE), magnetic resonance imaging and Positron emission tomography/computer tomography]. The study protocol was performed in accordance with the Ethics Committees of our institution. The need for consent to participate in this research study was waived in view of its observational and anonymous nature. The lockdown period in Belgium for the COVID-19 pandemic started on March 13th 2020. We compared the weekly incidence of definite endocarditis, using the ESC recommendations (Modified Duke Criteria), between the period before and after the lockdown [9]. The pre-lockdown and post-lockdown period included the time period from July 08th 2017 until March 13th (140 weeks) and from March 14th until May 1st 2020 (7 weeks). Our hospital installed from almost the beginning of the pandemic a strategy of broad Swap PCR testing to all hospitalized patients. Patients with COVID-positive testing are admitted to a special unit. Those who necessitate intensive care are admitted in a specially dedicated COVID intensive care unit. Waiting for the results of the Swap PCR, patients are admitted to a specially dedicated pre-COVID unit if they have symptoms of acute respiratory disease (fever, cough, dyspnea). If not they are admitted to the appropriate department, this in a single room with droplet infection protection measurements, until the result of the swap is known. Strategy for TTE and TEE’s has changed drastically in our hospital in the Corona pandemic, this in accordance with the recent paper of EACVI [10]. Indications are stricter to “only if really necessary and urgent––cannot be postponed”. This is even stricter for TOE since the risk inherent to this procedure. Protection materials are available in the hospital and used in accordance with EACVI recommendations. The mean number of admissions for definite IE per week before and after the lockdown period were compared using student’s t test. The Levene’s test for equality was used to assess the presence of equal variance and results are presented accordingly. Generalized linear model corrected for time as a continuous variable was used to estimate the change in the weekly incidence of IE in the period before and after the COVID lockdown. For visual representation (Fig. 1), the number of pre-lockdown period definite IE cases were clustered in periods of 7 weeks and compared with the 7 weeks of lockdown. A second figure (Fig. 2) illustrates the weekly numbers of the latest 21 weeks. Fig. 1 Graphical representation of the number of patients with definite IE represented by clusters of 7 weeks period. Last cluster of 7 weeks represents the lockdown period in Belgium. Superimposed are the numbers of TTE’s and TOE’s for each time cluster Fig. 2 Focus on the latest 21 weeks. Weekly numbers are shown Until April 30th, 11,654 Swap PCR tests were performed in our hospital. From these 11,654, 1784 (15, 3%) were positive for COVID-19. In the 140 weeks preceding the lockdown, 90 patients with IE were admitted in the hospital (0.64 ± 0.75/week). Most important patient characteristics are represented in Table 1. During the 7 weeks of lockdown we diagnosed one patient over a period of 7 weeks (0.14 ± 0.38/week) (p = 0.012). Our preliminary analysis during the phase of the COVID pandemic shows an estimated 55% (95% CI 6–115) reduction in IE cases. Table 1 Patient characteristics Patient characteristics N = 89 Age (years) 70.3 (± 13.9) Male 72% Prosthetic valve (incl. valvuloplasty) 48% ICD/CRT/PM device 34% IE type Native valve 48% Prosthetic valve 44% Device (ICD/CRT/PM) related 27% Microbiologic etiology Staph. aureus MS 18% Staph. aureus MR 1% Staph. coagulase negative 5% Streptoc. viridans 10% Streptoc. bovis 5% Pneumococcus 5% Enterococcus 18% In Fig. 1 the number of definite IE are represented in clusters of 7 weeks. Figure 2 is a focused image on the latest 21 weeks. Before lockdown, no time period had only one case of IE. Four had 2 cases. Except for hazard, this could also be explained for two of them by the coincidence with holiday––periods, which could be a trigger to postpone hospitalization. The Figures illustrate well the more dramatic decline of the numbers of IE to only one case exactly coinciding with the lockdown period. During the period before the lockdown, the number of TTE’s and TOE’s varied from 2819 to 3879 and 215–327 respectively. During the lockdown these numbers decreased to 1071 and 45 respectively. The number of TTE’s and TOE’s performed during each cluster of 7 weeks is represented in Fig. 1. One patient diagnosed during the lockdown presented with a late diagnosis. This 51-year-old man had a known cardiac murmur. He was first referred by his general practitioner to a COVID triage centre with fever and flu-like symptoms. He was sent home in quarantine. After a few days he presented to the emergency department of the hospital with the same complaints and received the same message. Since he developed “blurry” vision he was again referred by his general practitioner for a second time to the emergency department were the diagnosis was made of heart failure, cardiac murmur and a negative CT of the lungs for COVID-19, and an ischaemic zone was detected in the right cerebellum explaining the vision problems. Haemocultures were positive for Streptococcus parasanguinis and diagnosis was made of an extensive endocarditis of the mitral valve with vegetations on both anterior and posterior leaflet, with pseudo-aneurysm on the anterior leaflet, and massive mitral regurgitation on TTE and TOE. Naso-pharyngeal swab excluded again COVID-19 infection. Urgent surgery, confirming the diagnosis of IE of the mitral valve, was performed after coronary angiography demonstrating a significant lesion on the right coronary artery. In this manuscript we expose the possible harmful effect of lockdown measures imposed by the government on the detection rate of IE. Although numbers are small, inherent to a mono-centre evaluation of a rather rare disease, the results merit a word of caution towards the medical society and the policy makers. This underdiagnosis of IE might be due to a change in patient behavior, incorrect triage and underuse of the normal diagnostic tools. Until April 30th, 50,498 positive cases with COVID infection were reported in Belgium. Given the population of Belgium this is a relative big number. This can probably be explained by a return of infected Belgian skiers in the beginning of the COVID pandemic and by the broad testing. This also underlines the appropriateness of the lockdown in Belgium. IE remains a deadly disease and early diagnosis is the corner stone for early treatment and avoiding unnecessary complications [6, 9]. The first step for early diagnosis is recognizing the predisposing characteristics of the disease and the symptoms and signs linked to IE. Since fever, shortness of breath and cough are the major symptoms and signs of a COVID infection, but also of IE, the risk exists that the COVID pandemic dominates the medical attention towards a “war medicine” approach were these signs leads to quarantine measures and screening pathways by swap-PCR and CT lungs, ignoring possible differential diagnosis. Even if the physician would stay alert, the first step in a possible diagnosis is a fast presentation at the general practitioner and subsequently at the emergency department. In a period were quarantine is obligatory when signs of fever, cough or dyspnea are present, later presentation of possible IE patients is expected certainly when fear for hospitalisation is collectively present in the population during COVID-19 pandemic. Diagnosis of IE also necessitates a good physical examination followed by the necessary blood cultures and multimodality imaging. Also, these diagnostic tools are often missing in the COVID period. Physical contact necessary for a thorough heart auscultation is often avoided in the emergency department in suspicion of COVID infection. Although swap-PCR and CT lungs are liberally used, haemocultures are not always performed in the patient with fever if the clinical symptoms are not too severe and fever with respiratory complaints are dominating the clinical picture suggesting pulmonary infection eventually by COVID-19. The cornerstone for the diagnosis of IE besides haemocultures is and remains echocardiography. In a recent recommendation paper of EACVI, clear restrictions towards the use of TTE and certainly TOE in this COVID-19 period are proposed with obvious protection rules that need to be applied in case TTE and even more TOE is performed [10]. Importantly the paper also gives a clear recommendation for IE patients. The paper correctly alerts physicians that the frequency of IE can rise in this COVID-19 period related to less visits to the dentists and that patients with a suspicion of IE should continue to have a high priority for echocardiography [10]. It is clear however, that the diagnostic barrier imposed by the COVID 19 pandemic, implicates a potential harm for timely diagnosis and treatment in patients with IE. This report suggests a possible underdiagnosis of definite IE linked to lockdown measures imposed by the authorities in this COVID-19 pandemic. Even if numbers are small implicating a negative impact on strong statistical evidence, the paper gives enough elements to consider this problem and to increase our alertness for timely diagnosis and treatment of this deadly disease even in a COVID-19 pandemic.

          Related collections

          Most cited references6

          • Record: found
          • Abstract: found
          • Article: not found

          Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle

          Since December 2019, a total of 41 cases of pneumonia of unknown etiology have been confirmed in Wuhan city, Hubei Province, China. Wuhan city is a major transportation hub with a population of more than 11 million people. Most of the patients visited a local fish and wild animal market last month. At a national press conference held today, Dr Jianguo Xu, an academician of the Chinese Academy of Engineering, who led a scientific team announced that a new‐type coronavirus, tentatively named by World Health Organization as the 2019‐new coronavirus (2019‐nCoV), had caused this outbreak. 1 The 2019‐nCoV has a different coronavirus‐specific nucleic acid sequence from known human coronavirus species, which are similar to some of the beta coronaviruses identified in bats. 2 , 3 The virus‐specific nucleic acid sequences were detected in lung fluid, blood and throat swab samples in 15 patients and the virus that was isolated showed a typical coronavirus appearance under electron microscopy. Further research will be conducted to better understand the new coronavirus to develop antiviral agents and vaccines. 4 We applauded the excellent job that has been done so far. The infection was first described in December. Within 9 days, a special team consisted of physicians, scientists and epidemiologists who ruled out several extremely contagious pathogens including SARS, which killed hundreds of people more than a decade ago, and MERS. This has surely alleviated environmental concerns as Hong Kong authorities had quickly stepped up the disinfection of trains and airplanes and checks of passengers due to this outbreak. Most of the patients visited the fish and wild animal market last month in Wuhan. This fish and wild animal market also sold live animals such as poultry, bats, marmots, and snakes. All patients received prompt supportive treatment in quarantine. Among them, seven patients were in serious condition and one patient died. All of the 42 patients so far confirmed were from China except one Thailand patient who was a traveler from Wuhan. Eight patients have been cured of the disease and were discharged from the hospital last week. The 2019‐nCoV now have been isolated from multiple patients and appears to be the culprit. But the mystery has not been completely solved yet. Until there is a formal published scientific manuscript, the facts can be argued, particularly regarding causality despite these facts having been officially announced. The data collected so far is not enough to confirm the causal relationship between the new‐type coronavirus and the respiratory disease based on classical Koch's postulates or modified ones as suggested by Fredricks and Relman. 5 The viral‐specific nucleic acids were only discovered in 15 patients, and successful virus culture was extremely limited to only a few patients. There remains considerable work to be done to differentiate between colonization, shedding, and infection. Additional strains of the 2019‐nCoV need to be isolated to study their homologies. It is expected that antigens and monoclonal antibodies will be developed so serology can be used to confirm previous and acute infection status. The episode demonstrates further the need for rapid and accurate detection and identification methods that can be used in the local hospitals and clinics bearing the burden of identifying and treating patients. Recently, the Clinical Laboratory Improvement Amendments (CLIA) of 1988 has waived highly sensitive and specific molecular devices known as CLIA‐waived devices so that these devices are gradually becoming available for point of care testing. Finally, the epidemiological similarity between this outbreak and that of SARS in 2002‐2003 6 is striking. SARS was then traced to animal markets 7 and eventually to palm civets. 8 Later bats were identified as animal reservoirs. 9 Could this novel coronavirus be originated from wild animals? The family Coronaviridae includes two subfamilies. 10 One, the subfamily Coronavirinae, contains a substantial number of pathogens of mammals that individually cause a remarkable variety of diseases, including pneumonia. In humans, coronaviruses are among the spectrum of viruses that cause the common cold as well as more severe respiratory disease—specifically SARS and MERS, which are both zoonoses. The second subfamily, Torovirinae, contains pathogens of both terrestrial and aquatic animals. The genus Torovirus includes the type species, equine torovirus (Berne virus), which was first isolated from a horse with diarrhea, and the Breda virus, which was first isolated from neonatal calves with diarrhea. White bream virus from fish is the type species of the genus Bafinivirus. However, there is no evidence so far that the seafood from the fish and animal market caused 2019‐nCoV‐associated pneumonia. This epidemiologic similarity clearly provides a starting point for the further investigation of this outbreak. In the meantime, this fish and animal market has been closed until the epidemiological work determines the animal host of this novel coronavirus. Only then will the miracle be complete.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak

            Highlights • The novel coronavirus (2019-nCoV) pneumonia has caused 2033 confirmed cases, including 56 deaths in mainland China, by 2020-01-26 17:06. • We aim to estimate the basic reproduction number of 2019-nCoV in Wuhan, China using the exponential growth model method. • We estimated that the mean R 0 ranges from 2.24 to 3.58 with an 8-fold to 2-fold increase in the reporting rate. • Changes in reporting likely occurred and should be taken into account in the estimation of R 0.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel

              Abstract There is currently an outbreak of pneumonia of unknown aetiology in Wuhan, China. Although there are still several unanswered questions about this infection, we evaluate the potential for international dissemination of this disease via commercial air travel should the outbreak continue.
                Bookmark

                Author and article information

                Contributors
                guy.van.camp@olvz-aalst.be
                Journal
                Clin Res Cardiol
                Clin Res Cardiol
                Clinical Research in Cardiology
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                1861-0684
                1861-0692
                10 June 2020
                : 1-4
                Affiliations
                [1 ]GRID grid.416672.0, ISNI 0000 0004 0644 9757, Heart Center OLV Aalst, ; Moorselbaan 164, 9300 Aalst, Belgium
                [2 ]GRID grid.416672.0, ISNI 0000 0004 0644 9757, Department of Microbiology, , OLV Aalst, ; Moorselbaan 164, 9300 Aalst, Belgium
                Author information
                http://orcid.org/0000-0002-9815-8337
                Article
                1686
                10.1007/s00392-020-01686-x
                7286420
                32524195
                34afa5f9-b2b1-4731-988c-53a8708277b4
                © Springer-Verlag GmbH Germany, part of Springer Nature 2020

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                : 13 May 2020
                : 3 June 2020
                Categories
                Letter to the Editors

                Cardiovascular Medicine
                Cardiovascular Medicine

                Comments

                Comment on this article